Pharmaceutical manufacturer GlaxoSmithKline (GSK) announced that as of Jan. 1 it would no longer produce the asthma inhaler Flovent, one of the most popular preventive and maintenance treatments ...

Flovent is a common asthma inhaler that's been around since the 1990s. It contains a corticosteroid that prevents asthma attacks by reducing inflammation in the airway. Patients use the inhaler ...

knew how to prescribe Flovent," said Cohen. "It had been one of the few inhalers that children could use with this age appropriate spacer device." Part of Flovent's popularity had to do with the ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

Asthma inhaler access dropped from nearly 41% to nearly 35% between 2021 and 2023 among patients 18 and younger prescribed Flovent (fluticasone), researchers found. By comparison, young asthma ...

Many users of a common asthma inhaler are poised to lose it in the ... GSK, manufacturer of the popular branded asthma treatment Flovent, announced in June that it would begin making only an ...